EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

A Pilot Randomised Non‐Inferiority Trial of Auto‐Titrating Versus Fixed Continuous Positive Airway Pressure for Obesity Hypoventilation Syndrome With Severe Obstructive Sleep Apnoea

Yizhong Zheng iD, Amanda Piper iD, Keith Wong, Gislaine Gauthier, Craig L Phillips, Ronald Grunstein iD, Brendon J Yee

Respirology · 2026

DOI: 10.1002/resp.70151 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Respirology, 2026. Verfasst von Yizhong Zheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Woolcock Institute of Medical Research, Sydney, Australia. Hauptthemen laut MEDLINE: Continuous Positive Airway Pressure, Obesity Hypoventilation Syndrome, Sleep Apnea, Obstructive. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective Fixed CPAP (fCPAP) is the preferred first‐line ventilatory therapy in patients with obesity hypoventilation syndrome with severe obstructive sleep apnoea (OHS + sOSA). Auto‐titrating CPAP (APAP) is not recommended but has not been systematically evaluated in this population. Our pilot study aimed to provide feasibility data for a larger comparative effectiveness trial to determine whether APAP is non‐inferior to fCPAP for improving hypercapnic respiratory failure.

Methods

Participants with OHS + sOSA were randomised to either APAP or fCPAP for 3 months. The primary outcome was the change in PaCO 2 . Secondary outcomes included changes in quality of life and cardiovascular biomarkers. A sample size of 82 was needed to demonstrate non‐inferiority of APAP compared to fCPAP (assuming a non‐inferiority margin of −2.5 mmHg). To assess feasibility we aimed to recruit up to 44 participants in this pilot trial.

Results

Twenty‐eight of 84 screened participants were randomised (Mean ± SD: Age 55 ± 12.5 years, BMI 54 ± 9.9 kg m −2 , PaCO 2 49 ± 2.6 mmHg, AHI 88 ± 31 events/h) to APAP ( n = 15) or fCPAP ( n = 13). Mean adherence exceeded 4 h in both groups; however 25% of randomised participants did not complete the trial. Both treatments reduced PaCO 2 (fCPAP: −5.7 ± 1.6 mmHg, APAP: −4.1 ± 2.8 mmHg). Test of non‐inferiority for APAP versus fCPAP was inconclusive (mean ΔPaCO 2 difference = −1.7 mmHg (95% CI −5.0 to 1.6 mmHg)). Adherence and sleep quality improvements favoured fCPAP, while other outcomes were comparable.

Conclusion

The pilot study highlighted important challenges with recruitment and retention. While the study is not powered to confirm the non‐inferiority of APAP, some outcomes appeared to favour fCPAP and APAP use in OHS + sOSA should be approached cautiously. A larger study with protocol modifications is required to confirm these preliminary findings. Trial Registration ACTRN12618000379213. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=374259 . Assessing the Efficacy of Auto‐titrating versus Fixed Continuous Positive Airway Pressure in Obesity Hypoventilation Syndrome image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Continuous Positive Airway PressureObesity Hypoventilation SyndromeSleep Apnea, ObstructiveHumansPilot ProjectsMiddle AgedMaleFemaleQuality of LifeTreatment OutcomeAdultAgedSeverity of Illness IndexFeasibility Studies

Stichwörter der Autor:innen

cardiovascular diseasehypercapnic respiratory failureobesitypositive airway pressure therapyquality of lifesleepiness

Autor:innen und Institutionen

  • Woolcock Institute of Medical Research, Sydney, Australia.
  • Department of Respiratory and Sleep Medicine, St George Hospital, Sydney, Australia.
  • School of Clinical Medicine, University of New South Wales, Sydney, Australia.
  • Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Sydney, Australia.
  • Central Clinical School, University of Sydney, Sydney, Australia.
  • Macquarie Medical School, Macquarie University, Sydney, Australia.

ORCID-Profile: Yizhong Zheng, Amanda Piper, Ronald Grunstein

Zitieren

APA

Zheng, Y., Piper, A., Wong, K., Gauthier, G., Phillips, C. L., Grunstein, R., & Yee, B. J. (2026). A Pilot Randomised Non‐Inferiority Trial of Auto‐Titrating Versus Fixed Continuous Positive Airway Pressure for Obesity Hypoventilation Syndrome With Severe Obstructive Sleep Apnoea. Respirology. https://doi.org/10.1002/resp.70151

Vancouver

Zheng Y, Piper A, Wong K, Gauthier G, Phillips CL, Grunstein R, et al. A Pilot Randomised Non‐Inferiority Trial of Auto‐Titrating Versus Fixed Continuous Positive Airway Pressure for Obesity Hypoventilation Syndrome With Severe Obstructive Sleep Apnoea. Respirology. 2026. doi:10.1002/resp.70151

BibTeX
@article{Zheng2026,
  author = {Zheng, Yizhong and Piper, Amanda and Wong, Keith and Gauthier, Gislaine and Phillips, Craig L and Grunstein, Ronald and Yee, Brendon J},
  title = {A Pilot Randomised Non‐Inferiority Trial of Auto‐Titrating Versus Fixed Continuous Positive Airway Pressure for Obesity Hypoventilation Syndrome With Severe Obstructive Sleep Apnoea},
  journal = {Respirology},
  year = {2026},
  doi = {10.1002/resp.70151}
}
Kostenlos starten →